The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

1.07%Dividend Yield

Mar 26

$0.08

Dec 25

$0.42

Sep 25

$0.23

Jun 25

$0.13

Mar 25

$0.03

10Y Growth

19.24%

5Y Growth

N/A

3Y Growth

294.94%

1Y Growth

5.9%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PBE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

IBB

Mkt Cap0

iShares Nasdaq Biotechnology ETF, tracks a similar biotech index, making it a direct competitor in the biotech ETF space.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, offers exposure to the biotechnology sector, competing directly with PBE in terms of sector focus.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, focuses on biotech firms, closely competing with PBE's investment theme.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, targets the biotech industry, similar to PBE's investment strategy.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF, invests in healthcare innovation, including biotech, making it a competitor.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF, focuses on genomic revolution, directly competing with PBE's genome investment focus.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, targets biotech and healthcare breakthroughs, competing in the same niche as PBE.

Virtus Biotech Clinical Trials

BBC

Mkt Cap0

Virtus LifeSci Biotech Clinical Trials ETF, focuses on biotech clinical trials, offering a similar investment focus to PBE.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF, specifically targets the genomics sector, making it a direct competitor to PBE's genome focus.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF, focuses on genomics and immunology, competing with PBE's thematic investment approach.

Holdings

Regions

Sectors

About

The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

CEO

Country

United States

ISIN

US46137V7872

Listings

0 Comments

Share your thoughts

FAQ

What is Invesco Biotechnology & Genome stock price today?▼

The current price of PBE is $82.64 USD — it has increased by +2.47% in the past 24 hours. Watch Invesco Biotechnology & Genome stock price performance more closely on the chart.

What is Invesco Biotechnology & Genome stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Invesco Biotechnology & Genome stocks are traded under the ticker PBE.

Is Invesco Biotechnology & Genome stock price growing?▼

PBE stock has risen by +5.33% compared to the previous week, the month change is a +4.65% rise, over the last year Invesco Biotechnology & Genome has showed a +37.83% increase.

Does Invesco Biotechnology & Genome pay dividends?▼

Yes, PBE dividends are paid quarterly. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 1.07%.

In which sector is Invesco Biotechnology & Genome located?▼

Invesco Biotechnology & Genome operates in the Other sector.

When did Invesco Biotechnology & Genome complete a stock split?▼

Invesco Biotechnology & Genome has not had any recent stock splits.